Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine. Επικοινωνία Submitted by Στέργιος Πολύζος on Τρί, 07/02/2019 - 10:56
